Comunicato stampa

Edison Awards Recognize Ortho Clinical Diagnostics for Outstanding Product Innovation

21 aprile 2017 | 16.28

LETTURA: 3 minuti

RARITAN, New Jersey, April 21, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that it has been awarded an Edison Award™ for Global Product Innovation, for its ORTHO VISION^® Platform. ORTHO VISION is a portfolio of fully automated analyzers that test blood for compatibility with patients receiving blood transfusions.

Photo - https://mma.prnewswire.com/media/492772/Ortho_Clinical_Diagnostics_ORTHO_VISION_Max.jpg

The ORTHO VISION^® Platform is comprised of the ORTHO VISION and ORTHO VISION Max analyzers. Tailored to the needs of blood banks or hospitals, the ORTHO VISION platform helps improve workflow and supports the standardization of systems and processes, enabling labs to increase productivity while remaining operationally efficient. The distinguished Edison Award honors the products, services and solutions that represent the best in innovation from around the world.

"With comprehensive testing capabilities, the ORTHO VISION platform enables labs to automate their immunohematology testing menu. This helps labs deliver accurate results, even during staffing shortages and in the face of cost constraints," said Heidi Casaletto, vice president Transfusion Medicine at Ortho. "This prestigious recognition from The Edison Awards acknowledges our commitment to innovating and reimagining what's possible for our customers."

The innovative ORTHO VISION platform introduces:

In addition to this Edison Award, earlier this year, Ortho received two Global Business Excellence Awards, which honored the ORTHO VISION platform for its innovation and excellence. Also this year, Ortho was honored with an internationally recognized Gold Stevie Award for Global Customer Service for Ortho Care™, a comprehensive collection of high-quality lab services and resources provided to Ortho customers at hospitals, hospital networks, blood banks and independent labs to enhance their overall performance.

About Ortho Clinical DiagnosticsOrtho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 120 countries, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

Ortho Care™ is a trademark of Ortho Clinical Diagnostics.ORTHO VISION^® is a trademark of Ortho Clinical Diagnostics